
03 Feb 2022 Fundraising
Leukaemia UK awarded Christmas Grant to support life-saving research
Leukaemia UK are delighted to have been awarded a special Christmas Grant from Kusuma Trust UK.
The grant of £10,000 will support the life-saving leukaemia research projects that Leukaemia UK funds across the UK. This includes Leukaemia UK’s prestigious John Goldman Fellowships which fund novel research projects by early career researchers into treatments for leukaemia and Project Grants funding experienced researchers advancing the fundamental understanding of the disease.
Fiona Hazell, Chief Executive of Leukaemia UK, said “We are thrilled to have been awarded this grant from Kusuma Trust UK, which will help to support Leukaemia UK’s life-saving research programmes into kinder and more effective treatments. Kusuma Trust’s support will help us to progress the research that matters most to the tens of thousands of families impacted by a leukaemia diagnosis.”
The Kusuma Trust UK is a family led philanthropic trust established in 2010. The Trust gives grants to organisations based on shared values and mutual interests in the UK, Gibraltar and India. Its current areas of interest are creating access to opportunities, improving health and well-being, and investing in our communities and environment.”
The Kusuma Trust said “We were very impressed to learn about Leukaemia UK’s research into leukaemia and other blood cancers and related disorders, and how they are pioneering the development of improved care and support to those affected. We hope that our funding will help to continue doing this important work.”
This generous grant will go towards funding kinder and more effective treatments for leukaemia, such as the research being carried out by Dr Samanta Mariani into the role of macrophages in cases of infant leukaemia or by Dr Daniel Coleman into developing kinder treatments by targeting mutated RAS genes.
Related posts
28 November 2022
Leukaemia UK John Goldman Fellow awarded Professorship
Talented blood cancer researcher, Vignir Helgason, was awarded a Leukaemia UK John Goldman Fellowship in 2015, for his research into chronic myeloid leukaemia (CML). Since then, his research career has…
1 August 2022
A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia
A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for…
20 October 2023
Emerging leaders accolade for former Leukaemia UK John Goldman Fellows
Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…
12 December 2022
Widespread coverage of new leukaemia therapy shows promise in first trial patient
As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…